Trehalose

02. May 2018 One of the most common classes of excipients used in protein formulations are buffers. The aim of...

26. March 2018 Spray-dried protein formulations commonly require stabilising excipients to prevent protein degradation during processing and storage, and trehalose...

10. February 2018 Abstract Pulmonary delivery of protein therapeutics has considerable clinical potential for treating both local and systemic diseases....

23. January 2018 Abstract Glucagon is a peptide hormone used for the treatment of hypoglycemia; however, its clinical potential is...

22. January 2018 Novel drug excipients are required to achieve stable formulations of protein drug candidates. Synthetic glycopolymers have been...

14. December 2017 Purpose Artificial tears are widely used in the treatment of dry eye disease, although current formulations do...

08. October 2017 Increasing knowledge about the human microbiome has led to a growing awareness of the potential of applying...

20. September 2017 Aerosolized administration of biopharmaceuticals to the airways is a promising route for nasal and pulmonary drug delivery,...

21. August 2017 Solid lipid nanoparticles (SLN) containing rifabutin (RFB), with pulmonary administration purposes, were developed through a technique that...

19. June 2017 Abstract Within this work, we develop vesicles incorporating sub-unit antigens as solid dosage forms suitable for the...